Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2001, p. 7391-7402, Vol. 21, No. 21
Section of Animal Models and Retroviral
Vaccines1 and Section of Virus and Tumor
Biology,3 Basic Research Laboratory, Center
for Cancer Research, National Cancer Institute, Bethesda, Maryland
20892; Unite d'Epidemiologie et Physiopathologie des Virus
Oncogenes, Institut Pasteur, 75724 Paris cedex 15, France2; and Department of
Microbiology, Tokyo Medical and Dental University, Bunkyo-ku,
113-8519 Tokyo, Japan4
Received 25 June 2001/Returned for modification 6 August
2001/Accepted 10 August 2001
The proto-oncogene c-myb is essential for a
controlled balance between cell growth and differentiation. Aberrant
c-Myb activity has been reported for numerous human cancers, and
enforced c-Myb transcription can transform cells of lymphoid origin by
stimulating cellular proliferation and inhibiting apoptotic pathways.
Here we demonstrate that activation of the NF-
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.21.7391-7402.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Human T-Cell Lymphotropic Virus Type 1 Tax
Represses c-Myb-Dependent Transcription through Activation of
the NF-
B Pathway and Modulation of Coactivator Usage
B pathway by the
HTLV-1 Tax protein leads to transcriptional inactivation of c-Myb. This conclusion was supported by the fact that Tax mutants unable to stimulate the NF-
B pathway could not inhibit c-Myb transactivating functions. In addition, inhibition of Tax-mediated NF-
B activation by coexpression of I
B
restored c-Myb transcription, and Tax was
unable to block c-Myb transcription in a NEMO knockout cell line.
Importantly, physiological stimuli, such as signaling with the cellular
cytokines tumor necrosis factor alpha, interleukin 1 beta (IL-1
),
and lipopolysaccharide, also inhibited c-Myb transcription. These results uncover a new link between extracellular signaling and
c-Myb-dependent transcription. The mechanism underlying
NF-
B-mediated repression was identified as sequestration of the
coactivators CBP/p300 by RelA. Interestingly, an amino-terminal
deletion form of p300 lacking the C/H1 and KIX domains and unable to
bind RelA retained the ability to stimulate c-Myb transcription and
prevented NF-
B-mediated repression.
*
Corresponding author. Mailing address: NCI Ctr. for
Cancer Research BRL, Section of Animal Models and Retroviral Vaccines, 41 Library Dr., Bldg. 41, Room C303, Bethesda, MD 20892. Phone: (301)
402-0303. Fax: (301) 402-0055. E-mail:
cbeben{at}helix.nih.gov.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|